A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

Clinical trial NCT06533332 · RECRUITING

Trial details

NCT number: NCT06533332
Sponsor: EtiraRx Australia Pty Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Breast Cancer Metastatic Ovarian Cancer Metastatic Endometrial Cancer Metastatic Liver Cancer Metastatic Pancreatic Cancer

Start date: 2024-10-14
Primary completion: 2026-12-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.